Stay updated on Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.

Latest updates to the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe change updates the page revision from v3.3.1 to v3.3.2 and does not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.3.1 and removed Revision: v3.2.0, a minor site maintenance update.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the notice about a lapse in government funding and potential delays in website updates from the page. The core trial details and dates remain unchanged.SummaryDifference0.4%

- Check35 days agoChange DetectedAdded Melanoma and related topics (MedlinePlus Genetics) as related topics on the study page to provide quick access to additional context.SummaryDifference0.6%

- Check64 days agoChange DetectedCore content update: new operating-status notice due to funding lapse and a new genetics topic; page revision upgraded from v3.1.0 to v3.2.0.SummaryDifference4%

- Check71 days agoChange DetectedUpdated to v3.1.0 with removal of the Melanoma topic link and the older v3.0.2 note; overall content impact is minimal.SummaryDifference0.3%

Stay in the know with updates to Nivolumab with RT for Head & Neck Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with RT for Head & Neck Melanoma Clinical Trial page.